Thalassemia:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Thalassemia Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Thalassemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Thalassemia 23
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Thalassemia Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
HemaQuest Pharmaceuticals, Inc. 34
Clinical Trial Overview of HemaQuest Pharmaceuticals, Inc. 34
Shire Plc 35
Clinical Trial Overview of Shire Plc 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Emmaus Life Sciences, Inc. 37
Clinical Trial Overview of Emmaus Life Sciences, Inc. 37
Apotex, Inc. 38
Clinical Trial Overview of Apotex, Inc. 38
bluebird bio, Inc. 39
Clinical Trial Overview of bluebird bio, Inc. 39
Cerus Corporation 40
Clinical Trial Overview of Cerus Corporation 40
Celgene Corporation 41
Clinical Trial Overview of Celgene Corporation 41
Acceleron Pharma, Inc. 42
Clinical Trial Overview of Acceleron Pharma, Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
HaEmek Medical Center, Israel 43
Clinical Trial Overview of HaEmek Medical Center, Israel 43
National Heart, Lung, and Blood Institute 44
Clinical Trial Overview of National Heart, Lung, and Blood Institute 44
Children’s Hospital & Research Center Oakland 45
Clinical Trial Overview of Children’s Hospital & Research Center Oakland 45
The National Institute of Diabetes and Digestive and Kidney Diseases 46
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 46
Baylor College of Medicine 47
Clinical Trial Overview of Baylor College of Medicine 47
Shiraz University of Medical Sciences 48
Clinical Trial Overview of Shiraz University of Medical Sciences 48
Queen Mary Hospital 49
Clinical Trial Overview of Queen Mary Hospital 49
University of California, San Francisco 50
Clinical Trial Overview of University of California, San Francisco 50
Boston University 51
Clinical Trial Overview of Boston University 51
Washington University School of Medicine 52
Clinical Trial Overview of Washington University School of Medicine 52
Five Key Clinical Profiles 53
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 83


【レポート販売概要】

■ タイトル:Thalassemia:グローバル臨床試験レビューH2, 2013
■ 英文:Thalassemia Global Clinical Trials Review, H2, 2013
■ 発行日:2013年10月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162629
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。